Emulating Trials and Quantifying Bias: The Convergence of Health Technology Assessment Agency Real-World Evidence Guidance Author Reply

被引：0
|
作者：
Moler-Zapata, Silvia [1 ,3 ]
Hutchings, Andrew [1 ]
O'Neill, Stephen [1 ]
Silverwood, Richard J. [2 ]
Grieve, Richard [1 ]
机构：
[1] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, Fac Publ Hlth & Policy, London, England
[2] UCL, UCL Social Res Inst, Ctr Longitudinal Studies, London, England
[3] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Hlth Serv Res & Policy, Keppel St, London WC1E 7HT, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 02期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.jval.2023.12.003
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：267 / 269
页数：3
相关论文
共 50 条
  • [21] Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies First Results From the RCT DUPLICATE Initiative
    Franklin, Jessica M.
    Patorno, Elisabetta
    Desai, Rishi J.
    Glynn, Robert J.
    Martin, David
    Quinto, Kenneth
    Pawar, Ajinkya
    Bessette, Lily G.
    Lee, Hemin
    Garry, Elizabeth M.
    Gautam, Nileesa
    Schneeweiss, Sebastian
    CIRCULATION, 2021, 143 (10) : 1002 - 1013
  • [22] Real-world evidence and nonrandomized data in health technology assessment: use existing methods to address unmeasured confounding?
    Sammon, Cormac J.
    Leahy, Thomas P.
    Gsteiger, Sandro
    Ramagopalan, Sreeram
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (14) : 969 - 972
  • [23] R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment
    Simpson, Alex
    Ramagopalan, Sreeram, V
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (10) : 797 - 799
  • [24] THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT OF MEDICATIONS FOR RARE DISEASES
    Harwood, M.
    Deighton, A.
    Mickle, A.
    Qian, C.
    Szabo, S.
    VALUE IN HEALTH, 2019, 22 : S863 - S863
  • [25] The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment
    Cox, Oliver
    Sammon, Cormac
    Simpson, Alex
    Wasiak, Radek
    Ramagopalan, Sreeram
    Thorlund, Kristian
    VALUE IN HEALTH, 2022, 25 (07) : 1253 - 1256
  • [26] REAL-WORLD DATA TO SUPPORT SURROGATE ENDPOINT EVALUATION FOR HEALTH TECHNOLOGY ASSESSMENT
    Dupin, J.
    Thokagevistk, K.
    Emonnot, L.
    Micon, S.
    Benyounes, K.
    Haves, D.
    Civet, A.
    Pau, D.
    Le Dissez, C.
    Gally, S.
    Esnault, C.
    VALUE IN HEALTH, 2022, 25 (12) : S456 - S457
  • [27] The use of real-world data in health technology assessment of medications for rare diseases
    Qian, Christina J.
    Mickle, Alexis T.
    Deighton, Alison M.
    Harwood, Meagan M.
    Szabo, Shelagh M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 259 - 259
  • [28] Policy and practice: the role Real-World Data (RWD) in Health Technology Assessment
    de Waure, Chiara
    Petelos, Elena
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 217 - 217
  • [29] The use of Real-World Data (RWD) by Health Technology Assessment (HTA) agencies
    Karen, K.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 218 - 218
  • [30] LATEST TRENDS IN DESIGN OF CLINICAL TRIALS FOR REAL-WORLD HEALTH ECONOMIC EVIDENCE GENERATION
    Aggarwal, S.
    Kumar, S.
    Topaloglu, H.
    VALUE IN HEALTH, 2016, 19 (03) : A105 - A105
12345